Reclassification of medicines: VOLTAROL EMULGEL P

Home > Notice-board > Reclassification > Voltarol Emulgel P

Voltarol Pain-Eze Emulgel P

Novartis Consumer Health has applied to have Voltarol Pain-Eze Emulgel (diclofenac diethylammonium 1.16 per cent) classified as a general sale list medicine. The product is the same as Voltarol Emulgel, which is currently a pharmacy medicine and which will remain available

Consultation period: 25 June 2004 to 6 August 2004.

ARM 21: request to reclassify a product from P to GSL
(Microsoft Word document)

Reclassification
P to GSL

Status
Pending

Voltarol Emulgel P

Novartis Consumer Health has asked the Medicines and Healthcare products Regulatory Agency to add the relief of pain of non-serious arthritic conditions to the licensed indications for pharmacy sale of Voltarol Emulgel P (diclofenac diethylammonium 1.16 per cent w/w gel, equivalent to 1 per cent w/w diclofenac sodium).

Consultation period: 16 Mar 2003 to 27 June 2003.

ARM 8: request to extend the pharmacy availability of Voltarol Emulgel P
(Microsoft Word document)

Reclassification
extend pharmacy availability

Status
Completed